Obstetrics & Gynecology Doctors in Grove City, PA Accepting Medicare

4 Obstetrics & Gynecology doctors found. Showing 1 - 4

William Calvin Dundore Jr., M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 647 North Broad Street Ext, Wolf Creek Medical Associates, Grove City, PA 16127 Phone: 724-458-7737    Fax: 724-458-7388

Rand S Himes, DO Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 647 North Broad Street Ext, Grove City, PA 16127 Phone: 724-458-7737    Fax: 724-458-7388

Dr. Francis J Bassani Sr., D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 647 N Broad Street Ext, Wolf Creek Medical Associates, Grove City, PA 16127 Phone: 724-450-7004    Fax: 724-450-7013

Nicole Lynn Carlson, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 631 N Broad Street Ext, Grove City, PA 16127 Phone: 724-449-3245    Fax: 724-449-3233

News Archive

Illinois professor looks at daily survival strategies of Beirut's LGBTQ residents

Daily life in Beirut is subject to violence and an ever-changing series of disruptions - a reality that residents refer to as "al-wad" or "the situation."

Palliative care recipients live longer and in less pain, study finds

The New York Times: "In a study that sheds new light on the effects of end-of-life care, doctors have found that patients with terminal lung cancer who began receiving palliative care immediately upon diagnosis not only were happier, more mobile and in less pain as the end neared — but they also lived nearly three months longer.

Control and containment key to combating avian influenza

Containing the bird flu virus to the greatest extent possible and reducing the risk of infection in poultry and farmed free-range ducks will help to prevent a global human influenza pandemic, the Food and Agriculture Organization (FAO) has announced.

FDA approves Sinapis Pharma's IND for IV methamphetamine in treatment of acute stroke

Sinapis Pharma is pleased to announce that it has received notice from the FDA that its Investigational New Drug application (IND) for the use of IV methamphetamine for acute stroke was approved on April 9, 2010. "We have accomplished a great deal of work for a small company on a very tight budget. We have GMP drug ready for the Phase I clinical trial and the Phase I site is prepared to begin this protocol," said Dr. Donald Picker , the company CEO.

Read more Medical News

› Verified 7 days ago